Authors: De Souza, M.V.N.; Vasconcelos, T.R.A.
Source: Química Nova (Impresso), v. 28, n.4, p. 678-682, 2005.
Publisher: Sociedade Brasileira de Química
Abstract
Approximately every minute, somewhere in the world four people die from tuberculosis (TB), an infection of Mycobacterium tuberculosis with about 3 million deaths per year. In spite of these problems, unfortunaly, it is about 40 years that a novel drug was last introduced on the market. Due to the rapid spread of multi-drug resistant TB strains, resistant against all major anti-tuberculosis drugs, and the recent resurgence of the incidence of tuberculosis in association with the human immunodeficiency virus (HIV) infection and AIDS, we need urgently the development of new drugs to fight tuberculosis. This is covered in the present article.Keywords: tuberculosis, drugs, antibacterial. Document Type: Research Article DOI: http://dx.doi.org/10.1590/S0100-40422005000400022 Publication date: 1 de Agosto de 2005
